- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Protease inhibitor
Total 64185 results
-
Seoul National University HospitalKorean Society of Hematology Thrombosis Working PartyCompletedRecurrence | Bleeding | Cancer-associated Thrombosis | RivaroxabanKorea, Republic of
-
London Health Sciences CentreCompletedCentral Venous Catheter Thrombosis | NeoplasmCanada
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedAcute Coronary Syndrome (ACS)Canada, Italy, Poland, Sweden, United States, Spain, Austria, Denmark, France, Belgium, Israel, Germany, Russian Federation, United Kingdom
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan
-
Sichuan Provincial People's HospitalRecruiting
-
The Medicines CompanyWithdrawnHeparin-Induced Thrombocytopenia | Heparin-induced Thrombocytopenia and Thrombosis SyndromeUnited States
-
Prof. Stavros Konstantinides, MDEuropean Georges Pompidou HospitalTerminated
-
The Medicines CompanyCompleted
-
Kamada, Ltd.Completed
-
Irina ErmolaevaRecruitingChronic Kidney Diseases | Atrial Fibrillation | T2DM (Type 2 Diabetes Mellitus)Russian Federation
-
George Washington UniversityCompletedSeptic ShockUnited States
-
University of Illinois at ChicagoLa Jolla Pharmaceutical CompanyCompletedShock | Kidney Transplant; Complications | Hypotension and Shock | Intraoperative Hypotension | Shock, Surgical | Postoperative HypotensionUnited States
-
Alissa GubeliSpentysCompletedRadius Fracture DistalSwitzerland
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedAtrial FibrillationUnited States
-
Boehringer IngelheimCompleted
-
AstraZenecaTerminatedStroke Prevention in Patients With Atrial FibrillationSweden, Norway, Poland, United Kingdom, Finland, Denmark, United States, Czech Republic, Belgium
-
Shanghai Tong Ren HospitalRecruitingEarly PCSK9 Inhibitor on Ventricular RemodlingChina
-
National Institutes of Health Clinical Center (CC)Completed
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus IUnited States, Spain, Canada, Russian Federation, Romania, Belgium, South Africa
-
Azienda Ospedaliero, Universitaria Ospedali RiunitiRecruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingExcessive Supraventricular Ectopies or Short Atrial Runs (ESVEA)
-
Institute for Clinical and Experimental MedicineRecruiting
-
PfizerCompletedNon-valvular Atrial FibrillationJapan
-
Brigham and Women's HospitalCompletedVenous ThromboembolismUnited States
-
University Hospital, CaenUniversity Hospital, RouenCompletedPeritoneal Dialysis | Chronic Renal InsufficiencyFrance
-
Veralox TherapeuticsCelerionCompletedHeparin-induced ThrombocytopeniaUnited States
-
Hyogo College of MedicineCompleted
-
Mayo ClinicBristol-Myers Squibb; PfizerTerminated
-
Genuine Research Center, EgyptHorus for Pharmaceutical Industries, EgyptCompleted
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan
-
Encysive PharmaceuticalsGlaxoSmithKlineCompletedThrombosis | ThrombocytopeniaUnited States
-
Inhibrx, Inc.RecruitingEmphysema | Alpha 1-Antitrypsin DeficiencyUnited States, Australia, United Kingdom, New Zealand
-
Ono Pharmaceutical Co. LtdCompleted
-
Daiichi Sankyo, Inc.CompletedAtrial FibrillationSpain, Italy, Germany, Switzerland, Portugal, Belgium, Austria, Ireland, Netherlands, United Kingdom
-
Novartis PharmaceuticalsWithdrawnAtrial Fibrillation
-
Walter AgenoUnknownDeep Vein ThrombosisItaly
-
Mayo ClinicBristol-Myers SquibbWithdrawnPatent Foramen Ovale | Cardiac Implantable Electronic DeviceUnited States
-
OctapharmaWithdrawn
-
Medical University InnsbruckCompletedAchievement of a Sufficient Thrombosis Prohpylaxis in Clitically Ill Patients With Heparin ResistanceAustria
-
Sherief Abd-ElsalamUnknownPortal Vein ThrombosisEgypt
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of YM150Japan
-
Beijing Friendship HospitalChanghai Hospital; Peking Union Medical College Hospital; Peking University Cancer...Not yet recruitingLocally Advanced Rectal CancerChina
-
The Affiliated Hospital Of Guizhou Medical UniversityNot yet recruitingCombined Analysis of Polymorphisms and Dabigatran Pharmacokinetic Parameters
-
Loxo Oncology, Inc.Eli Lilly and CompanyCompleted